Engage as a Stakeholder, Researcher, or Citizen

Join the EURIPID Collaboration and contribute to advancing transparency in medicine pricing. Whether you’re a stakeholder, researcher, or citizen, your involvement supports our mission to improve access to affordable medicines across Europe. Explore opportunities to engage, share insights, and make a difference.

Access to EURIPID Data for Researchers

The EURIPID Collaboration supports the research of the academic sector in the field of medicinal product pricing and access to medicines. To get data, the below described procedure has to be followed.


Provision of EURIPID data to researchers

  • 1) Submission of application form
  • 2) Review and assessment of application
  • 3) Vote on application by BoP
  • 4) Data provision
  • 5) Concluding an agreement
  • 6) Start Research
  • 7) Quality Review (optional)
  • 8) Notification prior to publication

01

Submission of application form

At first, the application form has to be filled in and submitted by the applicant (see button in the menu above).

Review and assessment of application

After the applicant submitted the application, the EURIPID team reviews the application for clarity and feasibility. If necessary, the team goes back to the applicant. In the next step, the EURIPID Executive Committee assesses the applications if it is from the academic sector and of public interest. Requests for bachelor or master-theses are excluded. If the Executive Committee endorses the application, a formal voting procedure by the BoP will be initiated.

Vote on application by BoP

The BoP is responsible for making a decision on applications on a case-by-case basis. The applicant will be informed by the EURIPID team if the decision of the BoP was positive or negative. In case of a negative decision, the applicant will be informed by the EURIPID team on the reasons of rejecting the application. In case of a positive decision, the applicant will be informed by the EURIPID team on the further procedure.

Data provision

After a positive decision of the BoP, there are two different procedures.

  • Notification & data extract: If the request can be fulfilled with available means, the EURIPID team informs the applicant about the positive decision of the BoP and provides the requested data extract.
  • Query against payment: If the request cannot be fulfilled with available means and additional SQL programming is necessary, the EURIPID team informs the applicant to contact the information provision service of the Hungarian National Institute of Health Insurance Fund (NEAK). The information provision services initiates the necessary extra query against payment and provides the data extract.

Concluding an agreement

The research institute must sign an agreement in which the service, the fee, the deadlines, confidentiality clauses, and further obligations are settled. The results of the research shall be shared with and published by the EURIPID Collaboration.

Please note that in case of an information request from the European Union, only electronic signatures from trust service providers delivering Qualified Certificates for Electronic Signature are accepted. The list of approved providers is available here:
https://esignature.ec.europa.eu/efda/tl-browser/#/screen/home

In case of an information request outside the European Union,
options for electronic signature shall be approved on a case-by-case basis.

If an electronic signature cannot be used for signing the agreement,
then it can be signed in paper format.

Start Research

After the signature of the Confidentiality Disclosure Agreement and the agreement to share the results if the research, the applicant can start the research. The research should be strictly non-commercial and serve public interest, as defined in the WHA resolution on price transparency. Requests for bachelor or master-theses will therefore be declined.

Quality Review (optional)

If the applicant requested a quality check of the research based on EURIPID data in the application, the EURIPID team will conduct the quality review.

Notification prior to publication

The researcher has to share the final analysis with the EURIPID Collaboration for publication on the EURIPID public website once the article is published. The Euripid team reserves the right to be listed as co-author in publications, especially when a quality review of the analysis and/or input to the methodology was provided.

Researcher application

Please enable JavaScript in your browser to complete this form.
time-range, geographic coverage, data scope (price, volume), product type 0 of 1000 max characters.
Quality review is requested